Sofinnova Investments, Inc. Vertex Pharmaceuticals Inc Transaction History

Sofinnova Investments, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $45.7 Million - $51.1 Million	145,300 New	145,300 $51.1 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $44.9 Million - $50.5 Million	156,989 New	156,989 $45.3 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $4.76 Million - $5.92 Million	-20,245 Reduced 21.31%	74,758 $21.1 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $21 Million - $24.8 Million	95,003 New	95,003 $24.8 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $16 Million - $17.9 Million	-88,214 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $7.97 Million - $9.4 Million	42,514 Added 93.03%	88,214 $17.8 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $9.46 Million - $11 Million	45,700 New	45,700 $9.82 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $19.3 Million - $25.3 Million	-85,664 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $10.7 Million - $13.3 Million	-53,500 Reduced 38.44%	85,664 $20.4 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $2.91 Million - $3.91 Million	17,474 Added 14.36%	139,164 $30.5 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $11.9 Million - $13.4 Million	71,389 Added 141.92%	121,690 $20.6 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $8.28 Million - $9.58 Million	50,301 New	50,301 $9.23 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.